Central Obesity Index and Cardiovascular Risk Factors in Polycystic Ovary Syndrome

被引:16
|
作者
Costa, Eduardo Caldas [1 ]
Mafaldo Soares, Elvira Maria [1 ]
Araujo Moura Lemos, Telma Maria [1 ]
de Oliveira Maranhao, Tecia Maria [1 ]
Azevedo, George Dantas [1 ]
机构
[1] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil
关键词
Polycystic ovary syndrome/complications; anthropometry; risk factors; cardiovascular disease; insulin resistance; TO-HEIGHT RATIO; VISCERAL FAT; WOMEN; DISEASE; INFLAMMATION; ADIPOSITY; MEN;
D O I
10.1590/S0066-782X2010005000029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Women with polycystic ovary syndrome (PCOS) present a high prevalence of abdominal obesity which is associated with an increased cardiovascular risk. Objective: To verify the accuracy of the waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and the conicity index (CI) in the detection of cardiovascular risk factors (CVRF) in women with PCOS. Methods: The present transversal study allocated 102 women (26.5 +/- 5 years) with a diagnosis of PCOS, according to the Rotterdam criteria. Total cholesterol (TC), triglycerides (TG), LDL-cholesterol (HDL-C), HDL-cholesterol (HDL-C), fasting glucose, glucose after the oral glucose tolerance test (OGTT) and blood pressure (BP) were evaluated in all patients, in addition to the anthropometric variables. Results: The WHtR was the marker that presented significant positive correlations with the highest number of CVRF (BP, TG and post-OGTT glucose), whereas there was a negative correlation with HDL-C. All the evaluated anthropometric markers were positively correlated with BP, whereas WC and WHR also presented a positive correlation with TG. Regarding the accuracy for the detection of CVRF, the anthropometric markers presented a sensibility > 60%, especially the WHtR, which had a sensibility > 70%. Conclusion: The WHtR showed to be the most accurate anthropometric indicator for the prediction of CVRF. In this sense, we propose the inclusion of this easily-measured parameter in the clinical assessment for the screening of women with PCOS and CVRF. (Arq Bras Cardiol 2010;94(5):595-600)
引用
收藏
页码:633 / 638
页数:6
相关论文
共 50 条
  • [21] Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
    Pandurevic, Srdan
    Macut, Djuro
    Fanelli, Flaminia
    Pagotto, Uberto
    Gambineri, Alessandra
    [J]. BIOMOLECULES, 2021, 11 (09)
  • [22] Polycystic ovary syndrome and cardiovascular disease risk
    Legro R.S.
    [J]. Current Cardiovascular Risk Reports, 2009, 3 (1) : 65 - 70
  • [23] Insulin resistance in women with polycystic ovary syndrome contributed to cardiovascular disease risk factors independent of obesity.
    Rouzi, AA
    Ardawi, MM
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S209 - S209
  • [24] Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors
    Calzada, M.
    Lopez, N.
    Noguera, J. A.
    Mendiola, J.
    Torres, A. M.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (01) : 75 - 83
  • [25] The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome
    Aydin, Gultekin Adanas
    Ozsoy, Hilal Gulsum Turan
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (03): : 274 - 280
  • [26] Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors
    Shi, Yuhua
    Cui, Yuqian
    Sun, Xuedong
    Ma, Gang
    Ma, Zengxiang
    Gao, Qin
    Chen, Zi-Jiang
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 173 : 66 - 70
  • [27] Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome
    Mu, L.
    Li, R.
    Lai, Y.
    Zhao, Y.
    Qiao, J.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (05) : 541 - 548
  • [28] Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome
    L. Mu
    R. Li
    Y. Lai
    Y. Zhao
    J. Qiao
    [J]. Journal of Endocrinological Investigation, 2019, 42 : 541 - 548
  • [29] The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
    E. Kassi
    E. Diamanti-Kandarakis
    [J]. Journal of Endocrinological Investigation, 2008, 31 : 1124 - 1131
  • [30] Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors
    M. Calzada
    N. López
    J. A. Noguera
    J. Mendiola
    A. M. Torres
    [J]. Journal of Endocrinological Investigation, 2019, 42 : 75 - 83